Venky's shares tumbled as much as 5.8% to an intraday low of ₹1,523.30 on Friday, November 13, despite the integrated poultry producer staging a sharp earnings turnaround in the September quarter.
The sell-off caught retail desks off guard.
According to the regulatory filing, net profit after tax touched ₹14.6 crore for the second quarter, clawing back from a bruising loss of ₹26.53 crore recorded during the corresponding period last fiscal year. Revenue from operations jumped 33.1% year-on-year to ₹1,066 crore, compared to ₹801 crore in the previous year. Operating performance mirrored the top-line recovery. Earnings before interest, taxes, depreciation, and amortisation (EBITDA) hit ₹22.6 crore for the quarter, swinging sharply from an operating EBITDA loss of ₹31 crore posted in Q2FY26.
Yet the street dumped the stock within hours of AirNews.
By 1:20 pm on Friday, the equity traded 3.5% lower at ₹1,559.70 on the exchanges. The intraday slide dragged the stock down nearly 3% over the past month and wiped out calendar gains, pushing Venky's 1% into the red year-to-date. Over a trailing 12-month horizon, however, the counter retains an advance of about 16%.
| Financial Metric | Q2 Current Quarter | Q2 Previous Year | YoY Change |
|---|---|---|---|
| Net Profit / (Loss) | ₹14.60 crore | (₹26.53 crore) | Turned Profitable |
| Revenue from Operations | ₹1,066.00 crore | ₹801.00 crore | +33.1% |
| Operating EBITDA | ₹22.60 crore | (₹31.00 crore) | Turned Profitable |
| Intraday Low (NSE/BSE) | ₹1,523.30 | — | -5.8% |
| 12-Month Share Return | +16.0% | — | — |
Venky's core poultry operations anchored the revenue expansion, shaking off prior quarters plagued by erratic farmgate realizations and severe pricing volatility.
The Poultry and Poultry Products segment generated ₹513 crore during the quarter, retaining its role as the company's primary cash engine. Oilseed processing followed closely, clocking ₹494 crore in turnover. Meanwhile, the Animal Health Products division supplied ₹98 crore to total revenue.
Market Context: The divergence between quarterly operational recovery and Friday's share price liquidation reflects cautious positioning among market participants. Traders opted to offload positions despite positive EBITDA margins, locking in profits after the stock's 16% twelve-month advance rather than pricing in sustained poultry realization gains.
Alongside the headline financial metrics, the board approved key leadership appointments to reconstitute its supervisory bench.
Col. Ram Vasant Athavale joined the board as an Additional Director in the capacity of Independent Director. The appointment followed a formal recommendation by the Nomination and Remuneration Committee and remains subject to final shareholder ratification. Simultaneously, the board cleared the induction of Brig. Ashutosh Dattaray Nargolkar as an Additional Director designated in a Non-Executive, Non-Independent capacity.
The company stated in its statutory disclosure that neither Col. Athavale nor Brig. Nargolkar holds any familial or commercial relationship with existing board directors.
The company now heads into the second half of the fiscal year awaiting shareholder clearance for its board nominees, with market attention pinned squarely on whether feed input costs and poultry prices permit sustained segment operating margins above the breakeven line.